ESC 365 - Anticoagulation vs. LAA occlusion for stroke prevention

CCO Premium Access

Anticoagulation vs. LAA occlusion for stroke prevention

Session: Management of cardiac arrhythmias in patients with cancer

Topic: Cardiac Arrhythmias and Cardiac Implantable Electronic Device (CIED)

Speaker: Doctor C. Plummer (Newcastle Upon Tyne, GB)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Chris Plummer

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne (United Kingdom of Great Britain & Northern Ireland)

7 presentations

8 followers

3 more presentations in this session

Rate vs. rhythm control in drug-induced atrial fibrillation

Speaker: Associate Professor F. Guerra (Ancona, IT)

Cancer drug-induced QT prolongation: what to do?

Speaker: Doctor M. Fradley (Philadelphia, US)

Management of cardiac arrhythmias in patients with cancer - discussion

Access the full session

Management of cardiac arrhythmias in patients with cancer

Speakers: Doctor C. Plummer, Associate Professor F. Guerra, Doctor M. Fradley

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources